Critical review of the manner in which the efficacy of therapies for rosacea are evaluated

International Journal of Dermatology

Volumn 42, Issue 11, 2003, Pages 909-916

  Gupta, Aditya K ^a,b   Chaudhry, Maria M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Mediprobe Laboratories Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZELAIC ACID; DERMATOLOGICAL AGENT; ISOTRETINOIN; METRONIDAZOLE; SULFUR DERIVATIVE; TETRACYCLINE;

CLINICAL TRIAL; CUTANEOUS PARAMETERS; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; HUMAN; MEDICAL ASSESSMENT; MEDLINE; METHODOLOGY; PAPULE; PUSTULE; REVIEW; ROSACEA; SCORING SYSTEM; SKIN COLOR; SKIN EXAMINATION; TELANGIECTASIA;

HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); ROSACEA; SEVERITY OF ILLNESS INDEX;

EID: 0344444634     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01861.x     Document Type: Review

References (51)

1. Millikan L. Recognizing rosacea: Could you be misdiagnosing this common skin disorder? Postgrad Med 1999; 105: 149-158.
2. Jillson OF, Rosacea. Cutis 1994; 34: 137-138.
3. Zuber TJ, Rosacea. Dermatology 2000; 27: 309-319.
4. Thiboutot DM. Acne rosacea. Am Fam Phys 1994; 50: 1691-1697.
5. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2002; 46: 584-587.
6. Aronson IK, Rumsfield JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm 1987; 21: 346-351.
7. Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea. Arch Dermatol 1987; 123; 609-614.
8. Lowe NJ, Henderson T, Millikan LE et al. Topical metronidazole for severe and recalcitrant rosacea: A prospective open trial. Cutis 1989; 43: 283-286.
9. Lebwohl MG, Medansky RS, Russo CL, et al. The comparative efficacy of sodium sulfacetamide 10%/sulfur 5% (Sulfacet-R) lotion and metronidazole 0.75% (Metrogel) in the treatment of rosacea. J Geriatr Dermatol 1995; 3: 183-185.
10. Bjerke JR, Nyfors A, Austad J, et al. Metronidazole (Elyzol®) 1% cream vs. placebo cream in the treatment of rosacea. Clin Trials 1989; 26: 187-194.
11. Bitar A, Bourgouin J, Doré N, et al. A double-blind randomized study of metronidazole (Flagyl®) 1% cream in the treatment of acne rosacea a placebo-controlled study. Drug Invest 1990; 2: 242-248.
12. Nielsen PG. Treatment of rosacea with 1% metronidazole cream: A double blind study. Br J Dermatol 1983; 108: 327-332.
13. Jorrizo JL, Lebwohl M, Tobey RE. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: A double-blind clinical trial. J Am Acad Dermatol 1998; 39: 502-504.
14. Tan JKL. A new formulation containing sunscreen (SPF 15) and 1% metronidazole (Rosasol® cream) in the treatment of rosacea. Skin Ther Lett 2001; 6: 1-2.
15. Nielsen PG. A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br J Dermatol 1983; 109: 63-65.
16. Schachter D, Schachter RK, Long B, et al. Comparison of metronidazole cream versus oral tetracycline in patients with rosacea. Drug Invest 1991; 3: 220-224.
17. Sauder DN, Miller R, Gratton D, et al. The treatment of rosacea: The safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study. J Dermatol Treat 1997; 8: 79-85.
18. Wilkin JK, DeWitt S. Treatment of rosacea: Topical clindamycin versus oral tetracycline. Int J Dermatol 1993; 32: 65-67.
19. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 1994; 130: 319-324.
20. Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Int J Dermatol 1986; 25: 660-663.
21. Marsden JR, Shuster S, Neugebauer M. Response of rosacea to istotretinoin. Clin Exp Dermatol 1984; 9: 484-488.
22. Erdogan FG. Efficacy of low-dose istretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1989; 134: 884-885.
23. Carmichael AJ, Marks R, Graupe KA, et al. Topical azelaic acid in the treatment of rosacea. J Dermatol Treat 1993; 4: S19-S22.
24. Bjerke R, Fyrand O, Graupe K. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. Acta Derm Venereol 1999; 79: 456-459.
25. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 1999; 40: 961-965.
26. Dahl MV, Iarrat M, Kaplan D et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 2001; 45: 723-730.
27. Veien NK, Christiansen JV, Hjorth N, et al. Topical metronidazole in the treatment of rosacea. Cutis 1986; 109: 209-210.
28. Breneman DL, Stewart D, Hevia O, Drake LA. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis 1998; 61: 44-47.
29. MetroLotion Package Insert. Galderma Laboratories Inc, Forth Worth, TX, November 1998.
30. Dahl MV, Katz HI, Krueger GG, et al. Topical metronidazole maintains remission of rosacea. Arch Dermatol 1998; 134: 679-683.
31. Tan JKL, Girard C, Krol A, et al. Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea. J Cut Med Surg 2002; 6: 529-534.
32. Blom I, Hornmark AM. Topical treatment with sulfur 10 percent for rosacea. Acta Derm Venereol 1984; 64: 358-359.
33. Marks R, Ellis J. Comparative effectiveness of tetracycline and ampicillin in rosacea: A controlled trial. Lancet 1971; 2: 1049-1052.
34. Monk BE, Logan RA, Cook J et al. Topical metronidazole in the treatment of rosacea. J Dermatol Treat 1991; 2: 91-93.
35. Torresani C, Pavesi A, Manara GC. Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol 1997; 36: 938-946.
36. Turganmaa K, Reunala T. Isotretinoin treatment of rosacea. Acta Derm Venereol 1987; 67: 89-91.
37. Montes LF, Cordero AA, Kriner J, et al. Topical treatment of acne rosacea with benzoyl peroxide acetone gel. Cutis 1983; 32: 185-190.
38. Sneddon IB. A clinical trial of tetracycline in rosacea. Br J Dermatol 1966; 78: 649-652.
39. Saihan EM, Burton JL. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol 1980; 102: 443-445.
40. Utas S, Özbakir Ö, Turasan A, Utas C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 1999; 40: 433-435.
41. Go MJTH, Wuite J. Comparative study of triamcinolone acetonide and hydrocortisone 17-butyrate in rosacea with special regard to the rebound phenomenon. Dermatologica 1976; 152: 239-246.
42. Signore RJ, Park T. A pilot study of 5 percent permethrin cream versus 0.75 percent metronidazole gel in acne rosacea. Cutis 1995; 56: 177-179.
43. Aizawa H, Niimura M. Oral spironolactone therapy in male patients with rosacea. J Dermatol 1992; 19: 293-297.
44. Bamford JTM, Tilden RL, Blankush JL, et al. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 1999; 135: 659-663.
45. Vienne MP, Ochando N, Borrel MT, et al. Retinaldehyde alleviates rosacea. Dermatol 1999; 199: 53-56.
46. Pye RJ, Burton JL. Treatment of rosacea by metronidazole. The Lancet 1976; 1: 1211-1212.
47. Elewski BE. A novel treatment for acne vulgaris and rosacea. J Eur Acad Dermatol Venereol 2000; 14: 423-424.
48. Precise Color Communication. Minolta Canada Inc, Mississauga, Ont., Canada, 1994 (data of file).
49. Clarys P, Alewaeters K, Lambrecht R, et al. Skin color measurements: Comparison between three instruments. The Chromameter®, the DermaSpectrometer® and the Mexameter®. Skin Res Technol 2000; 6: 230-238.
50. Groth L. Cutaneous microdialysis: Methodology and validation. Acta Derm Venereol 1996; 197: 1-61.
51. Westerhof W, Wan Hasselt BAAM, Kammeijer A. Quantification of UV-induced erythema with a portable computer controlled chromameter. Photodermatol 1986; 3: 310-314.